‘A very paternalistic attitude’: why is female desire still not taken seriously?

In documentary The Pink Pill, the fight to provide access to the so-called ‘female Viagra’ exposes an industry that still discounts the needs of women ...
WNCT

FDA Grants Priority Review for Addyi® (flibanserin) Paving the Way for Expanded Access to Treat Low Sexual Desire in Postmenopausal Women

Addyi is the first and only FDA-approved, hormone-free pill clinically proven to treat low sexual desire in women RALEIGH, N.C., July 24, 2025 /PRNewswire/ -- Sprout Pharmaceuticals today announced ...
Yahoo

Meet the Addyi Pill—a.k.a. Pink Viagra: Why the FDA's New 2025 Approval Is a ‘Historic First’ for Women Over 50

Add Yahoo as a preferred source to see more of our stories on Google. Viagra, the little blue pill, has been a household name for more than a generation. And now women’s sexual health is finally ...
KRQE Blogs

Unprecedented Abstract Highlights Addyi’s Remarkable Effects on Low Libido among Breast Cancer Patients

IRVINE, CA – July 5, 2023 – The Ad Firm is thrilled to announce the publication of an abstract by Sprout Pharmaceuticals, showcasing the remarkable effects of Addyi (flibanserin) on low libido among ...
AOL

FDA OKs Addyi, a Libido-Enhancing Drug for Women After Menopause

Addyi, sometimes referred to as “female Viagra,” is now approved for use to treat low sex drive in postmenopausal women. MoMo Productions/Getty Images The Food and Drug Administration (FDA) expanded ...